Intervention not reported
Function ‐ · participants with CTEV (type of case (i.e. whether initial presentation or relapsed) not specified)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Foot alignment Pirani score. A lower score indicates better alignment. Scale from: 0 to 6. · participants with CTEV (type of case (i.e. whether initial presentation or relapsed) not specified)
1 finding from 1 review
Intervention not reported
Gait assessment · participants with CTEV (type of case (i.e. whether initial presentation or relapsed) not specified)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Health‐related quality of life · participants with CTEV (type of case (i.e. whether initial presentation or relapsed) not specified)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Adverse events · participants with CTEV (type of case (i.e. whether initial presentation or relapsed) not specified)
1 finding from 1 review
no estimate extracted
1 study · 5 participants
Low
Intervention not reported
Gait assessment · participants with CTEV at initial presentation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Health‐related quality of life · participants with CTEV at initial presentation
1 finding from 1 review
Intervention not reported
Adverse events · participants with CTEV at initial presentation
The intervention may leads to lower adverse events (low certainty).
1 finding from 1 review
Intervention not reported
Function · participants with resistant CTEV
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Foot alignment · participants with resistant CTEV
1 finding from 1 review
Intervention not reported
Gait assessment · participants with resistant CTEV
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Health‐related quality of life · participants with resistant CTEV
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Improvement (greater than 50% of time spent) heel‐toe walking Measured by parents' perception of toe walking frequency more than 50% of the time. · children with ITW gait
It is very uncertain whether botulinum toxin plus conservative treatment changes improvement (greater than 50% of time spent) heel‐toe walking… compared with conservative treatment only (very low certainty).
1 finding from 1 review
Active range of motion of the ankle joint · children with ITW gait
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change from baseline in passive ankle dorsiflexion range of movement · children with ITW gait
1 finding from 1 review
Pain · children with ITW gait
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Recurrence of ITW post‐treatment Assessed by improvement in toe walking based on Gait Analysis Classification An increase indicates improvement (an improvement indicated by a change in downgrading of the severe or 3, moderate or 2, and mild or 1 c... · children with ITW gait
1 finding from 1 review
Adverse events · children with ITW gait
It is very uncertain whether botulinum toxin plus conservative treatment changes adverse events compared with conservative treatment only (very low certainty).
1 finding from 1 review
Change in cardiac function: number of patients with EF < 45% · boys with DMD, normal cardiac examination and LVEF > 55% at baseline
It is very uncertain whether prophylactic perindopril (2 mg to 4 mg daily) changes change in cardiac function: number of patients with EF < 45% compared with placebo (very low certainty).
1 finding from 1 review
Change in Ejection fraction (%) · boys (aged 8 to 16 years old) with subclinical cardiomyopathy in DMD
1 finding from 1 review